Proficio Capital Partners LLC acquired a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 30,780 shares of the company’s stock, valued at approximately $404,000.
A number of other hedge funds also recently modified their holdings of the stock. Quest Partners LLC grew its position in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares during the last quarter. Everence Capital Management Inc. lifted its stake in Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock valued at $182,000 after buying an additional 960 shares during the period. Quarry LP increased its holdings in shares of Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,662 shares in the last quarter. Atria Investments Inc increased its holdings in shares of Pediatrix Medical Group by 9.0% during the third quarter. Atria Investments Inc now owns 27,124 shares of the company’s stock valued at $314,000 after acquiring an additional 2,238 shares in the last quarter. Finally, Illinois Municipal Retirement Fund increased its holdings in shares of Pediatrix Medical Group by 7.8% during the fourth quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company’s stock valued at $622,000 after acquiring an additional 3,411 shares in the last quarter. Institutional investors own 97.71% of the company’s stock.
Pediatrix Medical Group Trading Down 1.8 %
MD opened at $14.38 on Tuesday. The stock has a market cap of $1.23 billion, a PE ratio of -11.98, a PEG ratio of 1.74 and a beta of 1.49. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The business has a 50 day moving average of $14.08 and a 200-day moving average of $13.33. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on MD. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Macquarie began coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. Truist Financial increased their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday, February 21st. UBS Group upped their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Finally, Mizuho increased their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $17.08.
Pediatrix Medical Group Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More
- Five stocks we like better than Pediatrix Medical Group
- Russell 2000 Index, How Investors Use it For Profitable Trading
- How to Protect Your Portfolio When Inflation Is Rising
- How to Read Stock Charts for Beginners
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Invest in Blue Chip Stocks
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.